Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -200.32M | -223.59M | -207.36M | -1.01B | -1.00B |
| Total Depreciation and Amortization | 208.82M | 204.88M | 210.96M | 228.46M | 249.81M |
| Total Amortization of Deferred Charges | 167.62M | 164.00M | 157.59M | 144.05M | 133.04M |
| Total Other Non-Cash Items | 117.17M | 139.50M | 144.09M | 965.43M | 948.40M |
| Change in Net Operating Assets | 1.08M | 7.72M | -1.85M | -24.90M | -36.32M |
| Cash from Operations | 294.36M | 292.52M | 303.43M | 300.68M | 293.68M |
| Capital Expenditure | -8.89M | -12.41M | -11.72M | -12.37M | -10.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -81.90M | -81.90M | -65.30M | -64.61M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -175.21M | -167.02M | -166.73M | -134.83M | -113.26M |
| Cash from Investing | -266.00M | -261.33M | -243.76M | -211.81M | -124.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.63M | -550.63M | -550.63M | -- | -- |
| Issuance of Common Stock | 3.09M | 3.86M | 4.30M | 7.44M | 8.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.11M | -3.93M | -83.00K | -106.00K | -2.00K |
| Cash from Financing | -551.65M | -550.70M | -546.41M | 7.33M | 8.31M |
| Foreign Exchange rate Adjustments | 6.06M | 1.89M | 3.97M | -804.00K | -3.29M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -517.24M | -517.62M | -482.76M | 95.40M | 174.65M |